Autolus Therapeutics (AUTL) Enterprise Value (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.25% |
| Sep 30, 2025 | -193.16% |
| Jun 30, 2025 | -28.87% |
| Mar 31, 2025 | 57.50% |
| Dec 31, 2024 | 65.26% |
| Sep 30, 2024 | 6.85% |
| Jun 30, 2024 | 6.92% |
| Mar 31, 2024 | -216.04% |
| Dec 31, 2023 | 6.43% |
| Sep 30, 2023 | 16.56% |
| Jun 30, 2023 | 10.35% |
| Mar 31, 2023 | 10.30% |
| Dec 31, 2022 | -134.29% |
| Sep 30, 2022 | 24.63% |
| Jun 30, 2022 | 19.39% |
| Mar 31, 2022 | 13.45% |
| Dec 31, 2021 | -79.30% |
| Sep 30, 2021 | 19.99% |
| Jun 30, 2021 | 9.69% |
| Mar 31, 2021 | -30,408.65% |
| Dec 31, 2020 | 99.56% |
| Sep 30, 2020 | 16.14% |
| Jun 30, 2020 | 12.81% |
| Mar 31, 2020 | -15.45% |
| Dec 31, 2019 | 8.36% |
| Sep 30, 2019 | 13.77% |
| Jun 30, 2019 | -42.01% |
| Mar 31, 2019 | 13.39% |
| Dec 31, 2018 | 11.99% |
| Sep 30, 2018 | 6.69% |
| Jun 30, 2018 | -119.53% |